Literature DB >> 15031823

A comparison of 4 questionnaires to measure fatigue in postpoliomyelitis syndrome.

Herwin L Horemans1, Frans Nollet, Anita Beelen, Gustaaf J Lankhorst.   

Abstract

OBJECTIVE: To assess the comparability and reproducibility of 4 questionnaires used to measure fatigue in postpoliomyelitis syndrome (PPS).
DESIGN: Repeated-measures at a 3-week interval.
SETTING: University hospital. PARTICIPANTS: Convenience sample of 65 patients with PPS.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: The Fatigue Severity Scale (FSS), the Nottingham Health Profile (NHP) energy category, the Polio Problem List (PPL) fatigue item, and the Dutch Short Fatigue Questionnaire (SFQ).
RESULTS: Correlations of scores between questionnaires were all significant (P<.01) and ranged from.43 (between the NHP energy category and the PPL fatigue item) to.68 (between the PPL fatigue item and the SFQ). Scores on the second visit, normalized to a 0 to 100 scale, were: FSS, 78+/-15; NHP energy category, 47+/-35; PPL fatigue item, 81+/-17; and SFQ, 65+/-22. Except for the difference between the FSS and the PPL fatigue item, the differences in scores between the questionnaires were significant (P<.01). Scale analysis indicated that all questionnaires measured the same unidimensional construct. The reproducibility of the FSS, the PPL fatigue item, and the SFQ was moderate. The smallest detectable change was 1.5 points for the FSS, 2.0 points for the PPL fatigue item, and 1.9 points for the SFQ.
CONCLUSIONS: Although the questionnaires measure the same fatigue construct in PPS, the results are not interchangeable because the ranges of measurement differ. The NHP energy category, in particular, appeared to have a high detection threshold. The moderate reproducibility of the questionnaires indicates a lack of precision, especially when applied at the individual patient level.

Entities:  

Mesh:

Year:  2004        PMID: 15031823     DOI: 10.1016/j.apmr.2003.06.007

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model.

Authors:  Melloney L M Wijenberg; Sven Z Stapert; Sebastian Köhler; Yvonne Bol
Journal:  J Behav Med       Date:  2016-05-28

2.  Fatigue: an important feature of late-onset Pompe disease.

Authors:  Marloes L C Hagemans; Sabine P M van Schie; A Cecile J W Janssens; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

3.  The effects of a home-based arm ergometry exercise programme on physical fitness, fatigue and activity in polio survivors: protocol for a randomised controlled trial.

Authors:  Deirdre Murray; Dara Meldrum; Roisin Moloney; Anna Campion; Frances Horgan; Orla Hardiman
Journal:  BMC Neurol       Date:  2012-12-13       Impact factor: 2.474

4.  The extent of using mobility assistive devices can partly explain fatigue among persons with late effects of polio - a retrospective registry study in Sweden.

Authors:  I Santos Tavares Silva; K S Sunnerhagen; C Willén; I Ottenvall Hammar
Journal:  BMC Neurol       Date:  2016-11-18       Impact factor: 2.474

5.  Whole Body Vibration Methods with Survivors of Polio.

Authors:  Carolyn P Da Silva
Journal:  J Vis Exp       Date:  2018-10-17       Impact factor: 1.355

6.  Psychometric Properties of Three Fatigue Rating Scales in Individuals With Late Effects of Polio.

Authors:  Jan Lexell; Stina B Jonasson; Christina Brogardh
Journal:  Ann Rehabil Med       Date:  2018-10-31

7.  Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson's disease patients.

Authors:  Seyed-Mohammad Fereshtehnejad; Hasti Hadizadeh; Farzaneh Farhadi; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  Parkinsons Dis       Date:  2013-09-05

8.  COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia.

Authors:  Mostafa M Khodeir; Hassan A Shabana; Zafar Rasheed; Abdullah S Alkhamiss; Mohamed Khodeir; Mohammad S Alkhowailed; Sami Alharbi; Mansour Alsoghair; Suliman A Alsagaby; Waleed Al Abdulmonem
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.